Total Payments
$3,200
2024 Payments
$15.95
Companies
26
Transactions
231
Medicare Patients
2,138
Medicare Billing
$156,198
Payment Breakdown by Category
Food & Beverage$3,200 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,200 | 231 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,265 | 113 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $419.62 | 15 | $0 (2024) |
| Novo Nordisk Inc | $195.23 | 15 | $0 (2023) |
| Amgen Inc. | $166.35 | 13 | $0 (2022) |
| Lilly USA, LLC | $140.92 | 10 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $135.39 | 9 | $0 (2022) |
| GlaxoSmithKline, LLC. | $133.35 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $95.05 | 6 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $91.81 | 6 | $0 (2023) |
| ITI, Inc. | $81.99 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.95 | 1 | AstraZeneca Pharmaceuticals LP ($15.95) |
| 2023 | $924.93 | 56 | ABBVIE INC. ($322.56) |
| 2022 | $1,250 | 90 | ABBVIE INC. ($378.37) |
| 2021 | $1,009 | 84 | AbbVie Inc. ($563.67) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Diabetes | ||||||
| 10/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Respiratory | ||||||
| 10/19/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Diabetes | ||||||
| 10/12/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: PSYCHIATRY | ||||||
| 09/28/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Gastroenterology | ||||||
| 09/20/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Oncology | ||||||
| 08/30/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Neuroscience | ||||||
| 08/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/03/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Obesity | ||||||
| 07/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 581 | 734 | $87,508 | $46,768 |
| 2022 | 7 | 495 | 634 | $72,946 | $37,648 |
| 2021 | 11 | 534 | 746 | $78,366 | $40,740 |
| 2020 | 12 | 528 | 664 | $63,423 | $31,042 |
Total Patients
2,138
Total Services
2,778
Medicare Billing
$156,198
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 367 | $45,565 | $21,041 | 46.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 124 | 124 | $19,840 | $12,685 | 63.9% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 19 | 19 | $4,161 | $2,717 | 65.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 60 | $6,360 | $2,701 | 42.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $3,995 | $2,242 | 56.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 52 | 52 | $2,000 | $1,460 | 73.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,200 | $1,454 | 66.1% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 22 | 22 | $1,107 | $734.92 | 66.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 19 | 19 | $1,140 | $725.23 | 63.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 30 | 30 | $750.00 | $635.10 | 84.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $390.00 | $372.19 | 95.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 221 | 340 | $42,160 | $20,221 | 48.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 110 | 110 | $17,600 | $11,441 | 65.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 105 | $11,130 | $4,193 | 37.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 33 | $990.00 | $899.91 | 90.9% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 16 | 16 | $576.00 | $506.08 | 87.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 17 | 17 | $425.00 | $358.53 | 84.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 13 | $65.00 | $28.94 | 44.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 303 | $37,542 | $18,572 | 49.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 108 | 108 | $17,280 | $11,568 | 66.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 150 | $15,900 | $6,119 | 38.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 20 | 20 | $4,700 | $2,727 | 58.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 31 | 31 | $774.00 | $490.77 | 63.4% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 13 | 13 | $390.00 | $368.81 | 94.6% |
| 85610 | Blood test, clotting time | Office | 2021 | 18 | 65 | $585.00 | $278.85 | 47.7% |
About Alicia Sawyer
Alicia Sawyer is a Primary Care healthcare provider based in Clarksville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2017. The National Provider Identifier (NPI) number assigned to this provider is 1164947743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alicia Sawyer has received a total of $3,200 in payments from pharmaceutical and medical device companies, with $15.95 received in 2024. These payments were reported across 231 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,200).
As a Medicare-enrolled provider, Sawyer has provided services to 2,138 Medicare beneficiaries, totaling 2,778 services with total Medicare billing of $156,198. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Other Specialties Family
- Location Clarksville, IN
- Active Since 08/04/2017
- Last Updated 04/04/2024
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1164947743
Products in Payments
- VRAYLAR (Drug) $726.43
- FARXIGA (Drug) $343.98
- UBRELVY (Drug) $320.95
- QULIPTA (Drug) $217.22
- NURTEC ODT (Drug) $135.39
- TRELEGY ELLIPTA (Drug) $121.92
- ENTRESTO (Drug) $95.05
- XIFAXAN (Drug) $91.81
- Ozempic (Drug) $86.42
- CAPLYTA (Drug) $81.99
- BREZTRI (Drug) $75.64
- TRULICITY (Drug) $72.89
- Aimovig (Biological) $68.36
- EVENITY (Biological) $61.44
- TRINTELLIX (Drug) $58.19
- Rybelsus (Drug) $57.79
- Kerendia (Drug) $55.39
- MYRBETRIQ (Drug) $52.82
- SPRAVATO (Drug) $48.06
- Cologuard Collection Kit (Device) $43.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Clarksville
Katie Johnson, Aprn, APRN
Primary Care — Payments: $4,971
Primary Care $4,971
Sasha Johnson, Np-C, NP-C
Primary Care — Payments: $1,575
Primary Care $1,575
Holly Knott
Primary Care — Payments: $363.35
Primary Care $363.35
Mrs. Zoe Lowery, Fnp-Bc, FNP-BC
Primary Care — Payments: $293.50
Primary Care $293.50
Mrs. Sharon Whyte, Cnp, CNP
Primary Care — Payments: $147.98
Primary Care $147.98
Kelly Fus, Dnp, DNP
Primary Care — Payments: $117.39
Primary Care $117.39